NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Attention DermTech, Inc. ("DermTech") (NASDAQ: DMTK) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 3, 2022 and November 3, 2022.
If you suffered a loss on your investment in DermTech, contact us about potential recovery by using the link below. There is no cost or obligation to you.
https://www.wongesq.com/pslra-1/dermtech-class-action-submission-form/?prid=56496&wire=3
ABOUT THE ACTION: The class action against DermTech includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (1) the Company experienced challenges with collections from commercial payors; (2) as a result, there was a lower average selling price for the DermTech Melanoma Test; (3) as a result of the foregoing, the Company’s revenue growth would be adversely impacted; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
DEADLINE: December 15, 2023
Aggrieved DermTech investors only have until December 15, 2023 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
